Accendra Health, Inc. (ACH)
NYSE: ACH · Real-Time Price · USD
3.030
-0.300 (-9.01%)
At close: Jun 15, 2026, 4:00 PM EDT
3.000
-0.030 (-0.99%)
After-hours: Jun 15, 2026, 7:48 PM EDT
Accendra Health Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Accendra Health stock has a consensus rating of "Hold" and an average price target of $4.49. The average 1-year stock price forecast is 48.18% higher than the current stock price, while the lowest is $2.70 (-10.89%) and the highest is $6.00 (+98.02%).
Price Target: $4.49 (+48.18%)
Analyst Consensus: Hold
* Price targets were last updated on May 12, 2026.
Analyst Ratings
The average analyst rating for Accendra Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Reiterates $3 → $4.5 | Hold | Reiterates | $3 → $4.5 | +48.51% | May 12, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +98.02% | May 12, 2026 |
| Citi | Citi | Buy Reiterates $3.25 → $5 | Buy | Reiterates | $3.25 → $5 | +65.02% | May 12, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates $2.25 | Sell | Reiterates | $2.25 | -25.74% | Apr 1, 2026 |
Financial Forecast
Revenue This Year
2.57B
from 2.76B
Decreased by -6.78%
Revenue Next Year
2.68B
from 2.57B
Increased by 4.24%
EPS This Year
0.42
from 1.01
Decreased by -58.48%
EPS Next Year
0.69
from 0.42
Increased by 64.04%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.6B | ||
| Avg | 2.6B | ||
| Low | 2.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -5.3% | ||
| Avg | -6.8% | ||
| Low | -8.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.42 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -58.5% | ||
| Low | - |